E
Cyclo Therapeutics, Inc.
CYTH
$0.7206
$0.00991.39%
E
Sell
3/19/2024Downgrade
Cyclo Therapeutics, Inc. (CYTH) was downgraded to E+ from D- on 3/19/2024 due to a decline in the valuation index.
Cyclo Therapeutics, Inc. (CYTH) was downgraded to E+ from D- on 3/19/2024 due to a decline in the valuation index.
D
Sell
12/8/2023Upgraded
Cyclo Therapeutics, Inc. (CYTH) was upgraded to D- from E+ on 12/8/2023 due to an increase in the volatility index and total return index.
Cyclo Therapeutics, Inc. (CYTH) was upgraded to D- from E+ on 12/8/2023 due to an increase in the volatility index and total return index.
E
Sell
11/22/2023Downgrade
Cyclo Therapeutics, Inc. (CYTH) was downgraded to E+ from D- on 11/22/2023 due to a decline in the solvency index, volatility index and total return index.
Cyclo Therapeutics, Inc. (CYTH) was downgraded to E+ from D- on 11/22/2023 due to a decline in the solvency index, volatility index and total return index.
D
Sell
11/9/2023Upgraded
Cyclo Therapeutics, Inc. (CYTH) was upgraded to D- from E+ on 11/9/2023 due to an increase in the volatility index.
Cyclo Therapeutics, Inc. (CYTH) was upgraded to D- from E+ on 11/9/2023 due to an increase in the volatility index.
E
Sell
10/25/2023Downgrade
Cyclo Therapeutics, Inc. (CYTH) was downgraded to E+ from D- on 10/25/2023 due to a decline in the volatility index and total return index.
Cyclo Therapeutics, Inc. (CYTH) was downgraded to E+ from D- on 10/25/2023 due to a decline in the volatility index and total return index.
D
Sell
10/5/2023Upgraded
Cyclo Therapeutics, Inc. (CYTH) was upgraded to D- from E+ on 10/5/2023 due to an increase in the volatility index.
Cyclo Therapeutics, Inc. (CYTH) was upgraded to D- from E+ on 10/5/2023 due to an increase in the volatility index.
E
Sell
9/20/2023Downgrade
Cyclo Therapeutics, Inc. (CYTH) was downgraded to E+ from D- on 9/20/2023 due to a decline in the volatility index.
Cyclo Therapeutics, Inc. (CYTH) was downgraded to E+ from D- on 9/20/2023 due to a decline in the volatility index.
D
Sell
8/30/2023Upgraded
Cyclo Therapeutics, Inc. (CYTH) was upgraded to D- from E+ on 8/30/2023 due to an increase in the volatility index and total return index.
Cyclo Therapeutics, Inc. (CYTH) was upgraded to D- from E+ on 8/30/2023 due to an increase in the volatility index and total return index.
E
Sell
8/15/2023Downgrade
Cyclo Therapeutics, Inc. (CYTH) was downgraded to E+ from D- on 8/15/2023 due to a noticeable decline in the solvency index, growth index and volatility index. Debt to equity increased from -0.04 to -0.01, the quick ratio declined from 0.23 to 0.15, and total revenue declined 23.16% from $152.4 to $117.1.
Cyclo Therapeutics, Inc. (CYTH) was downgraded to E+ from D- on 8/15/2023 due to a noticeable decline in the solvency index, growth index and volatility index. Debt to equity increased from -0.04 to -0.01, the quick ratio declined from 0.23 to 0.15, and total revenue declined 23.16% from $152.4 to $117.1.
D
Sell
8/3/2023Upgraded
Cyclo Therapeutics, Inc. (CYTH) was upgraded to D- from E+ on 8/3/2023 due to an increase in the total return index and volatility index.
Cyclo Therapeutics, Inc. (CYTH) was upgraded to D- from E+ on 8/3/2023 due to an increase in the total return index and volatility index.
E
Sell
3/14/2023Downgrade
Cyclo Therapeutics, Inc. (CYTH) was downgraded to E+ from D on 3/14/2023 due to a decline in the volatility index.
Cyclo Therapeutics, Inc. (CYTH) was downgraded to E+ from D on 3/14/2023 due to a decline in the volatility index.
D
Sell
2/9/2023Upgraded
Cyclo Therapeutics, Inc. (CYTH) was upgraded to D from E+ on 2/9/2023 due to an increase in the volatility index.
Cyclo Therapeutics, Inc. (CYTH) was upgraded to D from E+ on 2/9/2023 due to an increase in the volatility index.
E
Sell
2/8/2023Downgrade
Cyclo Therapeutics, Inc. (CYTH) was downgraded to E+ from D on 2/8/2023 due to a decline in the solvency index. The quick ratio declined from 3.74 to 1.63.
Cyclo Therapeutics, Inc. (CYTH) was downgraded to E+ from D on 2/8/2023 due to a decline in the solvency index. The quick ratio declined from 3.74 to 1.63.
D
Sell
10/19/2022Upgraded
Cyclo Therapeutics, Inc. (CYTH) was upgraded to D from D- on 10/19/2022 due to an increase in the volatility index.
Cyclo Therapeutics, Inc. (CYTH) was upgraded to D from D- on 10/19/2022 due to an increase in the volatility index.
D
Sell
10/3/2022Downgrade
Cyclo Therapeutics, Inc. (CYTH) was downgraded to D- from D on 10/3/2022 due to a decline in the volatility index.
Cyclo Therapeutics, Inc. (CYTH) was downgraded to D- from D on 10/3/2022 due to a decline in the volatility index.
D
Sell
9/8/2022Upgraded
Cyclo Therapeutics, Inc. (CYTH) was upgraded to D from D- on 9/8/2022 due to an increase in the volatility index.
Cyclo Therapeutics, Inc. (CYTH) was upgraded to D from D- on 9/8/2022 due to an increase in the volatility index.
D
Sell
5/16/2022Upgraded
Cyclo Therapeutics, Inc. (CYTH) was upgraded to D- from E+ on 5/16/2022 due to an increase in the volatility index.
Cyclo Therapeutics, Inc. (CYTH) was upgraded to D- from E+ on 5/16/2022 due to an increase in the volatility index.
E
Sell
5/13/2022Downgrade
Cyclo Therapeutics, Inc. (CYTH) was downgraded to E+ from D on 5/13/2022 due to a decline in the total return index.
Cyclo Therapeutics, Inc. (CYTH) was downgraded to E+ from D on 5/13/2022 due to a decline in the total return index.
D
Sell
5/4/2022Upgraded
Cyclo Therapeutics, Inc. (CYTH) was upgraded to D from E+ on 5/4/2022 due to an increase in the valuation index.
Cyclo Therapeutics, Inc. (CYTH) was upgraded to D from E+ on 5/4/2022 due to an increase in the valuation index.
E
Sell
5/1/2022Downgrade
Cyclo Therapeutics, Inc. (CYTH) was downgraded to E+ from D on 5/1/2022 due to a decline in the total return index.
Cyclo Therapeutics, Inc. (CYTH) was downgraded to E+ from D on 5/1/2022 due to a decline in the total return index.
D
Sell
4/21/2022Upgraded
Cyclo Therapeutics, Inc. (CYTH) was upgraded to D from E+ on 4/21/2022 due to an increase in the volatility index.
Cyclo Therapeutics, Inc. (CYTH) was upgraded to D from E+ on 4/21/2022 due to an increase in the volatility index.
E
Sell
4/20/2022Downgrade
Cyclo Therapeutics, Inc. (CYTH) was downgraded to E+ from D on 4/20/2022 due to a decline in the solvency index, volatility index and total return index.
Cyclo Therapeutics, Inc. (CYTH) was downgraded to E+ from D on 4/20/2022 due to a decline in the solvency index, volatility index and total return index.
D
Sell
3/7/2022Upgraded
Cyclo Therapeutics, Inc. (CYTH) was upgraded to D from D- on 3/7/2022 due to an increase in the volatility index.
Cyclo Therapeutics, Inc. (CYTH) was upgraded to D from D- on 3/7/2022 due to an increase in the volatility index.
D
Sell
2/16/2022Downgrade
Cyclo Therapeutics, Inc. (CYTH) was downgraded to D- from D on 2/16/2022 due to a decline in the volatility index and total return index.
Cyclo Therapeutics, Inc. (CYTH) was downgraded to D- from D on 2/16/2022 due to a decline in the volatility index and total return index.
D
Sell
1/27/2022Upgraded
Cyclo Therapeutics, Inc. (CYTH) was upgraded to D from D- on 1/27/2022 due to an increase in the volatility index and total return index.
Cyclo Therapeutics, Inc. (CYTH) was upgraded to D from D- on 1/27/2022 due to an increase in the volatility index and total return index.
D
Sell
1/11/2022Downgrade
Cyclo Therapeutics, Inc. (CYTH) was downgraded to D- from D on 1/11/2022 due to a decline in the volatility index, solvency index and total return index. The quick ratio declined from 3.84 to 2.57.
Cyclo Therapeutics, Inc. (CYTH) was downgraded to D- from D on 1/11/2022 due to a decline in the volatility index, solvency index and total return index. The quick ratio declined from 3.84 to 2.57.
D
Sell
11/9/2021Upgraded
Cyclo Therapeutics, Inc. (CYTH) was upgraded to D from E+ on 11/09/2021.
Cyclo Therapeutics, Inc. (CYTH) was upgraded to D from E+ on 11/09/2021.
E
Sell
11/8/2021Downgrade
Cyclo Therapeutics, Inc. (CYTH) was downgraded to E+ from D on 11/8/2021 due to a decline in the total return index and growth index.
Cyclo Therapeutics, Inc. (CYTH) was downgraded to E+ from D on 11/8/2021 due to a decline in the total return index and growth index.
D
Sell
9/3/2021Upgraded
Cyclo Therapeutics, Inc. (CYTH) was upgraded to D from D- on 9/3/2021 due to an increase in the valuation index and volatility index.
Cyclo Therapeutics, Inc. (CYTH) was upgraded to D from D- on 9/3/2021 due to an increase in the valuation index and volatility index.
D
Sell
8/19/2021Downgrade
Cyclo Therapeutics, Inc. (CYTH) was downgraded to D- from D on 8/19/2021 due to a decline in the valuation index, growth index and total return index. Total revenue declined 33.37% from $358.1 to $238.6.
Cyclo Therapeutics, Inc. (CYTH) was downgraded to D- from D on 8/19/2021 due to a decline in the valuation index, growth index and total return index. Total revenue declined 33.37% from $358.1 to $238.6.
D
Sell
5/14/2021Upgraded
Cyclo Therapeutics, Inc. (CYTH) was upgraded to D from D- on 5/14/2021 due to a substantial increase in the solvency index, growth index and valuation index. Total revenue increased 145.95% from $145.6 to $358.1, debt to equity declined from 0.02 to 0.01, and earnings per share increased from -$1.296 to -$0.7568.
Cyclo Therapeutics, Inc. (CYTH) was upgraded to D from D- on 5/14/2021 due to a substantial increase in the solvency index, growth index and valuation index. Total revenue increased 145.95% from $145.6 to $358.1, debt to equity declined from 0.02 to 0.01, and earnings per share increased from -$1.296 to -$0.7568.
D
Sell
2/26/2021Downgrade
Cyclo Therapeutics, Inc. (CYTH) was downgraded to D- from D on 2/26/2021 due to a decline in the total return index.
Cyclo Therapeutics, Inc. (CYTH) was downgraded to D- from D on 2/26/2021 due to a decline in the total return index.
D
Sell
2/11/2021Upgraded
Cyclo Therapeutics, Inc. (CYTH) was upgraded to D from D- on 2/11/2021 due to an increase in the total return index.
Cyclo Therapeutics, Inc. (CYTH) was upgraded to D from D- on 2/11/2021 due to an increase in the total return index.
D
Sell
1/27/2021Downgrade
Cyclo Therapeutics, Inc. (CYTH) was downgraded to D- from D on 1/27/2021 due to a decline in the total return index and volatility index.
Cyclo Therapeutics, Inc. (CYTH) was downgraded to D- from D on 1/27/2021 due to a decline in the total return index and volatility index.
D
Sell
12/9/2020Upgraded
Cyclo Therapeutics, Inc. (CTDH) was upgraded to D from D- on 12/9/2020 due to an increase in the volatility index and total return index.
Cyclo Therapeutics, Inc. (CTDH) was upgraded to D from D- on 12/9/2020 due to an increase in the volatility index and total return index.
D
Sell
7/8/2020Downgrade
Cyclo Therapeutics, Inc. (CTDH) was downgraded to D- from D on 7/8/2020 due to a decline in the volatility index.
Cyclo Therapeutics, Inc. (CTDH) was downgraded to D- from D on 7/8/2020 due to a decline in the volatility index.
D
Sell
6/19/2020Upgraded
Cyclo Therapeutics, Inc. (CTDH) was upgraded to D from D- on 6/19/2020 due to an increase in the volatility index.
Cyclo Therapeutics, Inc. (CTDH) was upgraded to D from D- on 6/19/2020 due to an increase in the volatility index.
D
Sell
6/2/2020Downgrade
Cyclo Therapeutics, Inc. (CTDH) was downgraded to D- from D on 6/2/2020 due to a decline in the volatility index and total return index.
Cyclo Therapeutics, Inc. (CTDH) was downgraded to D- from D on 6/2/2020 due to a decline in the volatility index and total return index.
D
Sell
5/15/2020Upgraded
Cyclo Therapeutics, Inc. (CTDH) was upgraded to D from D- on 5/15/2020 due to a noticeable increase in the growth index and valuation index. Total revenue increased 43.23% from $227.4 to $325.7, operating cash flow increased 18.5% from -$2.22M to -$1.81M, and earnings per share increased from -$0.022 to -$0.0218.
Cyclo Therapeutics, Inc. (CTDH) was upgraded to D from D- on 5/15/2020 due to a noticeable increase in the growth index and valuation index. Total revenue increased 43.23% from $227.4 to $325.7, operating cash flow increased 18.5% from -$2.22M to -$1.81M, and earnings per share increased from -$0.022 to -$0.0218.
D
Sell
4/30/2020Upgraded
Cyclo Therapeutics, Inc. (CTDH) was upgraded to D- from E+ on 4/30/2020 due to an increase in the volatility index and valuation index.
Cyclo Therapeutics, Inc. (CTDH) was upgraded to D- from E+ on 4/30/2020 due to an increase in the volatility index and valuation index.
E
Sell
4/15/2020Downgrade
Cyclo Therapeutics, Inc. (CTDH) was downgraded to E+ from D- on 4/15/2020 due to a large decline in the growth index, solvency index and total return index. Earnings per share declined from -$0.0134 to -$0.022, EBIT declined 61.97% from -$1.63M to -$2.64M, and the quick ratio declined from 2.15 to 0.93.
Cyclo Therapeutics, Inc. (CTDH) was downgraded to E+ from D- on 4/15/2020 due to a large decline in the growth index, solvency index and total return index. Earnings per share declined from -$0.0134 to -$0.022, EBIT declined 61.97% from -$1.63M to -$2.64M, and the quick ratio declined from 2.15 to 0.93.
D
Sell
3/27/2020Downgrade
Cyclo Therapeutics, Inc. (CTDH) was downgraded to D- from D on 3/27/2020 due to a decline in the volatility index and growth index.
Cyclo Therapeutics, Inc. (CTDH) was downgraded to D- from D on 3/27/2020 due to a decline in the volatility index and growth index.
D
Sell
11/29/2019Upgraded
Cyclo Therapeutics, Inc. (CTDH) was upgraded to D from D- on 11/29/2019 due to an increase in the solvency index and volatility index.
Cyclo Therapeutics, Inc. (CTDH) was upgraded to D from D- on 11/29/2019 due to an increase in the solvency index and volatility index.
D
Sell
8/15/2019Downgrade
CTD Holdings, Inc. (CTDH) was downgraded to D- from D+ on 8/15/2019 due to a significant decline in the efficiency index, volatility index and solvency index. Debt to equity increased from -0.02 to 0.
CTD Holdings, Inc. (CTDH) was downgraded to D- from D+ on 8/15/2019 due to a significant decline in the efficiency index, volatility index and solvency index. Debt to equity increased from -0.02 to 0.
D
Sell
5/16/2019Upgraded
CTD Holdings, Inc. (CTDH) was upgraded to D+ from D on 5/16/2019 due to a significant increase in the efficiency index, solvency index and valuation index.
CTD Holdings, Inc. (CTDH) was upgraded to D+ from D on 5/16/2019 due to a significant increase in the efficiency index, solvency index and valuation index.
D
Sell
8/31/2018Upgraded
CTD Holdings, Inc. (CTDH) was upgraded to D from D- on 8/31/2018 due to a noticeable increase in the total return index, growth index and valuation index.
CTD Holdings, Inc. (CTDH) was upgraded to D from D- on 8/31/2018 due to a noticeable increase in the total return index, growth index and valuation index.
D
Sell
8/16/2018Downgrade
CTD Holdings, Inc. (CTDH) was downgraded to D- from D on 8/16/2018 due to a substantial decline in the growth index and efficiency index. Earnings per share declined from -$0.0111 to -$0.02, EBIT declined 58.98% from -$814.4 to -$1.29M, and net income declined 58.59% from -$812.9 to -$1.29M.
CTD Holdings, Inc. (CTDH) was downgraded to D- from D on 8/16/2018 due to a substantial decline in the growth index and efficiency index. Earnings per share declined from -$0.0111 to -$0.02, EBIT declined 58.98% from -$814.4 to -$1.29M, and net income declined 58.59% from -$812.9 to -$1.29M.
D
Sell
5/17/2018Upgraded
CTD Holdings, Inc. (CTDH) was upgraded to D from D- on 5/17/2018 due to a substantial increase in the growth index and total return index. Earnings per share increased from -$0.019 to -$0.0111, EBIT increased 41.27% from -$1.39M to -$814.4, and operating cash flow increased 25.19% from -$986.1 to -$737.7.
CTD Holdings, Inc. (CTDH) was upgraded to D from D- on 5/17/2018 due to a substantial increase in the growth index and total return index. Earnings per share increased from -$0.019 to -$0.0111, EBIT increased 41.27% from -$1.39M to -$814.4, and operating cash flow increased 25.19% from -$986.1 to -$737.7.
D
Sell
4/17/2018Downgrade
CTD Holdings, Inc. (CTDH) was downgraded to D- from D on 4/17/2018 due to a significant decline in the growth index, solvency index and volatility index. Earnings per share declined from -$0.0087 to -$0.019, EBIT declined 117.71% from -$636.9 to -$1.39M, and operating cash flow declined 70.52% from -$578.3 to -$986.1.
CTD Holdings, Inc. (CTDH) was downgraded to D- from D on 4/17/2018 due to a significant decline in the growth index, solvency index and volatility index. Earnings per share declined from -$0.0087 to -$0.019, EBIT declined 117.71% from -$636.9 to -$1.39M, and operating cash flow declined 70.52% from -$578.3 to -$986.1.
D
Sell
11/13/2017Upgraded
CTD Holdings, Inc. (CTDH) was upgraded to D from D- on 11/13/2017 due to an increase in the growth index, efficiency index and solvency index. Net income increased 23.45% from -$827.8 to -$633.7, EBIT increased 23.35% from -$830.9 to -$636.9, and earnings per share increased from -$0.0114 to -$0.01.
CTD Holdings, Inc. (CTDH) was upgraded to D from D- on 11/13/2017 due to an increase in the growth index, efficiency index and solvency index. Net income increased 23.45% from -$827.8 to -$633.7, EBIT increased 23.35% from -$830.9 to -$636.9, and earnings per share increased from -$0.0114 to -$0.01.
D
Sell
5/17/2016Downgrade
CTD Holdings Inc. (CTDH) was downgraded to D- from D on 5/17/2016 due to a noticeable decline in the efficiency index, solvency index and volatility index. The quick ratio declined from 1.88 to 1.23, total capital declined 16.69% from $4.5M to $3.75M, and debt to equity increased from 0.2 to 0.23.
CTD Holdings Inc. (CTDH) was downgraded to D- from D on 5/17/2016 due to a noticeable decline in the efficiency index, solvency index and volatility index. The quick ratio declined from 1.88 to 1.23, total capital declined 16.69% from $4.5M to $3.75M, and debt to equity increased from 0.2 to 0.23.
D
Sell
3/11/2016Downgrade
CTD Holdings Inc. (CTDH) was downgraded to D from D+ on 3/11/2016 due to a significant decline in the volatility index and total return index.
CTD Holdings Inc. (CTDH) was downgraded to D from D+ on 3/11/2016 due to a significant decline in the volatility index and total return index.
D
Sell
11/13/2015Downgrade
CTD Holdings Inc. (CTDH) was downgraded to D+ from C- on 11/13/2015 due to a major decline in the growth index, efficiency index and solvency index. Total revenue declined 38.29% from $380.3 to $234.7.
CTD Holdings Inc. (CTDH) was downgraded to D+ from C- on 11/13/2015 due to a major decline in the growth index, efficiency index and solvency index. Total revenue declined 38.29% from $380.3 to $234.7.
C
Hold
8/14/2015Upgraded
CTD Holdings Inc. (CTDH) was upgraded to C- from D on 8/14/2015 due to a significant increase in the growth index and valuation index. Total revenue increased 119.57% from $173.2 to $380.3.
CTD Holdings Inc. (CTDH) was upgraded to C- from D on 8/14/2015 due to a significant increase in the growth index and valuation index. Total revenue increased 119.57% from $173.2 to $380.3.
D
Sell
6/19/2015Downgrade
CTD Holdings Inc. (CTDH) was downgraded to D from D+ on 6/19/2015 due to a decline in the total return index.
CTD Holdings Inc. (CTDH) was downgraded to D from D+ on 6/19/2015 due to a decline in the total return index.
D
Sell
6/1/2015Upgraded
CTD Holdings Inc. (CTDH) was upgraded to D+ from D on 6/1/2015 due to an increase in the valuation index.
CTD Holdings Inc. (CTDH) was upgraded to D+ from D on 6/1/2015 due to an increase in the valuation index.
D
Sell
5/15/2015Downgrade
CTD Holdings Inc. (CTDH) was downgraded to D from D+ on 5/15/2015 due to a large decline in the growth index, volatility index and efficiency index. Total revenue declined 61.17% from $446 to $173.2, and total capital declined 7.48% from $5.16M to $4.78M.
CTD Holdings Inc. (CTDH) was downgraded to D from D+ on 5/15/2015 due to a large decline in the growth index, volatility index and efficiency index. Total revenue declined 61.17% from $446 to $173.2, and total capital declined 7.48% from $5.16M to $4.78M.
D
Sell
3/27/2015Downgrade
CTD Holdings Inc. (CTDH) was downgraded to D+ from C- on 3/27/2015 due to a noticeable decline in the growth index and efficiency index. Total capital declined 4.7% from $5.42M to $5.16M.
CTD Holdings Inc. (CTDH) was downgraded to D+ from C- on 3/27/2015 due to a noticeable decline in the growth index and efficiency index. Total capital declined 4.7% from $5.42M to $5.16M.
C
Hold
11/14/2014Upgraded
CTD Holdings Inc. (CTDH) was upgraded to C- from D+ on 11/14/2014 due to a noticeable increase in the growth index, volatility index and solvency index. Total revenue increased 123.21% from $173.6 to $387.5, earnings per share increased from -$0.0029 to -$0.0041, and debt to equity declined from 0.26 to 0.18.
CTD Holdings Inc. (CTDH) was upgraded to C- from D+ on 11/14/2014 due to a noticeable increase in the growth index, volatility index and solvency index. Total revenue increased 123.21% from $173.6 to $387.5, earnings per share increased from -$0.0029 to -$0.0041, and debt to equity declined from 0.26 to 0.18.
D
Sell
9/3/2014Downgrade
CTD Holdings Inc. (CTDH) was downgraded to D+ from C- on 9/3/2014 due to a large decline in the total return index.
CTD Holdings Inc. (CTDH) was downgraded to D+ from C- on 9/3/2014 due to a large decline in the total return index.
C
Hold
8/25/2014Downgrade
CTD Holdings Inc. (CTDH) was downgraded to C- from C on 8/25/2014 due to a noticeable decline in the total return index.
CTD Holdings Inc. (CTDH) was downgraded to C- from C on 8/25/2014 due to a noticeable decline in the total return index.
C
Hold
8/21/2014Downgrade
CTD Holdings Inc. (CTDH) was downgraded to C from C+ on 8/21/2014 due to a significant decline in the growth index, efficiency index and total return index. Net income declined 256.24% from $96.9 to -$151.4, EBIT declined 234.58% from $158.2 to -$212.9, and earnings per share declined from $0.0023 to -$0.0029.
CTD Holdings Inc. (CTDH) was downgraded to C from C+ on 8/21/2014 due to a significant decline in the growth index, efficiency index and total return index. Net income declined 256.24% from $96.9 to -$151.4, EBIT declined 234.58% from $158.2 to -$212.9, and earnings per share declined from $0.0023 to -$0.0029.
C
Hold
8/11/2014Upgraded
CTD Holdings Inc. (CTDH) was upgraded to C+ from C on 8/11/2014 due to a large increase in the solvency index, total return index and growth index. Total revenue increased 139.24% from $234.2 to $560.3, the quick ratio increased from 1.85 to 4.12, and debt to equity declined from 0.47 to 0.36.
CTD Holdings Inc. (CTDH) was upgraded to C+ from C on 8/11/2014 due to a large increase in the solvency index, total return index and growth index. Total revenue increased 139.24% from $234.2 to $560.3, the quick ratio increased from 1.85 to 4.12, and debt to equity declined from 0.47 to 0.36.
C
Hold
4/30/2014Downgrade
CTD Holdings Inc. (CTDH) was downgraded to C from C+ on 4/30/2014 due to a noticeable decline in the valuation index and volatility index.
CTD Holdings Inc. (CTDH) was downgraded to C from C+ on 4/30/2014 due to a noticeable decline in the valuation index and volatility index.
C
Hold
4/2/2014Downgrade
CTD Holdings Inc. (CTDH) was downgraded to C+ from B- on 4/2/2014 due to a large decline in the valuation index.
CTD Holdings Inc. (CTDH) was downgraded to C+ from B- on 4/2/2014 due to a large decline in the valuation index.
B
Buy
3/5/2014Downgrade
CTD Holdings Inc. (CTDH) was downgraded to B- from B+ on 3/5/2014 due to a substantial decline in the valuation index and efficiency index. Net income declined 10.69% from -$94.5 to -$84.4, and total capital declined 4.91% from $2.78M to $2.65M.
CTD Holdings Inc. (CTDH) was downgraded to B- from B+ on 3/5/2014 due to a substantial decline in the valuation index and efficiency index. Net income declined 10.69% from -$94.5 to -$84.4, and total capital declined 4.91% from $2.78M to $2.65M.
NASDAQ
03/25/2025 4:00PM Eastern
Quotes delayed
